- Home
- ROIV vs DBX Comparison
ROIV vs DBX Comparison
Compare ROIV & DBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | DBX |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 6.2B |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ROIV | DBX |
|---|---|---|
| Price | $26.53 | $22.14 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 8 |
| Target Price | $27.56 | ★ $28.14 |
| AVG Volume (30 Days) | ★ 4.4M | 3.2M |
| Earning Date | 02-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.86 |
| EPS | N/A | ★ 1.86 |
| Revenue | ★ $29,053,000.00 | N/A |
| Revenue This Year | N/A | $0.20 |
| Revenue Next Year | $594.84 | N/A |
| P/E Ratio | ★ N/A | $12.25 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $22.43 |
| 52 Week High | $30.33 | $32.40 |
Technical Indicators
Market Signals| Indicator | ROIV | DBX |
|---|---|---|
| Relative Strength Index (RSI) | 42.52 | 22.43 |
| Support Level | $20.46 | N/A |
| Resistance Level | $27.94 | $29.01 |
| Average True Range (ATR) | 0.88 | 0.73 |
| MACD | -0.38 | -0.38 |
| Stochastic Oscillator | 1.04 | 4.37 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About DBX Dropbox Inc.
Dropbox provides cloud storage and content collaboration tools, focusing on individuals and small to midsize businesses. Founded in 2007, Dropbox was a pioneer in the file sync and share market. In recent years, the firm has been emphasizing its Dash product, which facilitates AI-powered universal search across unstructured cloud data.